Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AptaBio Therapeutics Inc.

www.aptabio.com

Latest From AptaBio Therapeutics Inc.

Start-Up Quarterly Statistics: Early Funding Declined, But Deal Dollars Flowed

A review of biopharma startup dealmaking and financing activity from January through March 2017, based on data from Strategic Transactions, showed a 19% decline in startup financing compared with the fourth quarter of 2016, but big pharmas provided capital in the form of alliance fees.

StartUps and SMEs Financing
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Cardiovascular
  • Metabolic Disorders
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • South Korea
  • Parent & Subsidiaries
  • AptaBio Therapeutics Inc.
  • Senior Management
  • SooJin Lee, PhD, CEO
    SungHwan Moon, PhD, Pres. & CSO
  • Contact Info
  • AptaBio Therapeutics Inc.
    Phone: 10 2073 6801
    16954 Tower Bldg #504, Heungdeok-1-ro
    Giheung-gu
    Yongin-City,
    South Korea
Advertisement
Advertisement
UsernamePublicRestriction

Register